Psychiatric Effects of GLP-1s (What We Know So Far)
Apple Podcasts Apple Podcasts 
iHeartRadio iHeartRadio 
Spotify Spotify 
PocketCasts PocketCasts 
Castbox Castbox 
Podcast Addict Podcast Addict 
Overcast Overcast 
Pandora Pandora 
Amazon Music Amazon Music 
Castro Castro 
Audible Audible 
PlayerFM PlayerFM 
Podchaser Podchaser 
Deezer Deezer 
Goodpods Goodpods 
Audacy Audacy 
RSS Feed Apple Podcasts Apple Podcasts iHeartRadio iHeartRadio Spotify Spotify PocketCasts PocketCasts Castbox Castbox Podcast Addict Podcast Addict Overcast Overcast Pandora Pandora Amazon Music Amazon Music Castro Castro Audible Audible PlayerFM PlayerFM Podchaser Podchaser Deezer Deezer Goodpods Goodpods Audacy Audacy In this episode, Margaret and I take on the en vogue topic of GLP-1s. They have been utilized for T2DM for several years and just recently took center stage in the zeitgeist for weight loss (medically indicated or otherwise). Today, we will break down possible risks to mental health in patients using these medications and, on the flipside, potential areas where we could possibly use GLP-1s primarily to treat mental illness.
Paper used:
Sa B, Maristany A, Subramaniam A, et al. Psychiatric effects of GLP-1 receptor agonists: A systematic review of emerging evidence. Diabetes Obes Metab. 2026;28(1):50-59. doi:10.1111/dom.70198
Watch on YouTube: @itspresro
Listen Anywhere You Podcast: Apple, Spotify, PodChaser, etc.
—
Produced by Dr Glaucomflecken & Human Content
Get in Touch: howtobepatientpod.com
Learn more about your ad choices. Visit megaphone.fm/adchoices
